Genetic susceptibility to lung cancer and co-morbidities

Journal of Thoracic Disease

Volumn 5, Issue SUPPL.5, 2013, Pages

  Yang, Ian A ^a,b   Holloway, John W ^c,d   Fong, Kwun M ^a,b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Academic Unit of Human Development and Health   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chronic obstructive; Genetics; Genome wide association study (GWAS); Lung cancer; Pulmonary disease

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

BAT3 GENE; CANCER PROGNOSIS; CHRNA3 GENE; CHRNA5 GENE; CHROMOSOME 15Q; CHROMOSOME 5P; CHROMOSOME 6P; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLPTM1L GENE; COMORBIDITY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HERITABILITY; HUMAN; LINKAGE ANALYSIS; LUNG CANCER; MSH5 GENE; PERSONALIZED MEDICINE; PHARMACOGENETICS; POPULATION RISK; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; SMOKING HABIT; TERT GENE; TUMOR GENE;

EID: 84904747623     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.08.06     Document Type: Review

References (85)

1. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997, 89, 1580-6.
2. Mathers C, Vos T. The burden of disease and injury in australia-summary report. Canberra: Australian Institute of Health and Welfare, 1999.
3. Sriram KB, Larsen JE, Yang IA, et al. Genomic medicine in non-small cell lung cancer: paving the path to personalized care. Respirology 2011, 16, 257-63.
4. Fong KM, Yang IA, Bowman RV. Personalized medicine for lung cancer. Lung Cancer Management 2012, 1, 83-6.
5. Sriram KB, Tan ME, Savarimuthu SM, et al. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer. Eur Respir J 2011, 38, 903-10.
6. Brennan P, Hainaut P, Boffetta P. Genetics of lung-cancer susceptibility. Lancet Oncol 2011, 12, 399-408.
7. Marshall AL, Christiani DC. Genetic susceptibility to lung cancer--light at the end of the tunnel? Carcinogenesis 2013, 34, 487-502.
8. Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA 2004, 292, 2977-83.
9. Sellers TA, Chen PL, Potter JD, et al. Segregation analysis of smokingassociated malignancies: evidence for Mendelian inheritance. Am J Med Genet 1994, 52, 308-14.
10. Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 2002, 99, 260-6.
11. Braun MM, Caporaso NE, Page WF, et al. A cohort study of twins and cancer. Cancer Epidemiol Biomarkers Prev 1995, 4, 469-73.
12. Tyndale RF. Genetics of alcohol and tobacco use in humans. Ann Med 2003, 35, 94-121.
13. Lorenzo Bermejo J, Hemminki K. Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2005, 14, 1738-40.
14. Peddle L, Rahman P. Genetic epidemiology of complex phenotypes. Methods Mol Biol 2009, 473, 187-201.
15. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004, 75, 460-74.
16. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173, 16-22.
17. International HapMap Consortium. A haplotype map of the human genome. Nature 2005, 437, 1299-320.
18. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science 2008, 322, 881-8.
19. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008, 9, 356-69.
20. Amos CI. Successful design and conduct of genome-wide association studies. Hum Mol Genet 2007, 16 Spec No. 2:R220-5.
21. Lam AC, Powell J, Wei WH, et al. A combined strategy for quantitative trait loci detection by genome-wide association. BMC Proc 2009, 3 Suppl 1:S6.
22. Frazer KA, Murray SS, Schork NJ, et al. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009, 10, 241-51.
23. Zhang R, Zhao Y, Chu M, et al. Pathway analysis for genome-wide association study of lung cancer in Han Chinese population. PLoS One 2013, 8:e57763.
24. Spinola M, Leoni VP, Galvan A, et al. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene. Cancer Lett 2007, 251, 311-6.
25. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008, 40, 616-22.
26. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452, 633-7.
27. Liu P, Vikis HG, Wang D, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst 2008, 100, 1326-30.
28. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452, 638-42.
29. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008, 40, 1404-6.
30. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008, 40, 1407-9.
31. Broderick P, Wang Y, Vijayakrishnan J, et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 2009, 69, 6633-41.
32. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009, 85, 679-91.
33. Hsiung CA, Lan Q, Hong YC, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 2010, 6:e1001051.
34. Li Y, Sheu CC, Ye Y, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010, 11, 321-30.
35. Miki D, Kubo M, Takahashi A, et al. Variation in Tp63 Is Associated with Lung Adenocarcinoma Susceptibility in Japanese and Korean Populations. Nat Genet 2010, 42, 893-6.
36. Yoon KA, Park JH, Han J, et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet 2010, 19, 4948-54.
37. Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 2011, 43, 792-6.
38. Ahn MJ, Won HH, Lee J, et al. The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet 2012, 131, 365-72.
39. Dong J, Jin G, Wu C, et al. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese. PLoS Genet 2013, 9:e1003190.
40. Lan Q, Hsiung CA, Matsuo K, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012, 44, 1330-5.
41. Shiraishi K, Kunitoh H, Daigo Y, et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet 2012, 44, 900-3.
42. Timofeeva MN, Hung RJ, Rafnar T, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet 2012, 21, 4980-95.
43. Kim JH, Park K, Yim SH, et al. Genome-wide association study of lung cancer in korean non-smoking women. J Korean Med Sci 2013, 28, 840-7.
44. Dong J, Hu Z, Wu C, et al. Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet 2012, 44, 895-9.
45. Wei S, Wang LE, McHugh MK, et al. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis 2012, 33, 1531-7.
46. Wu C, Xu B, Yuan P, et al. Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer. Pharmacogenet Genomics 2010, 20, 389-95.
47. Wu X, Ye Y, Rosell R, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst 2011, 103, 817-25.
48. Lee Y, Yoon KA, Joo J, et al. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Carcinogenesis 2013, 34, 307-13.
49. West KA, Brognard J, Clark AS, et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003, 111, 81-90.
50. Tournier JM, Birembaut P. Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr Opin Oncol 2011, 23, 83-7.
51. Al-Wadei HA, Al-Wadei MH, Schuller HM. Cooperative regulation of nonsmall cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. PLoS One 2012, 7:e29915.
52. Mocellin S, Verdi D, Pooley KA, et al. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 2012, 104, 840-54.
53. Truong T, Hung RJ, Amos CI, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010, 102, 959-71.
54. Khayyata S, Yun S, Pasha T, et al. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol 2009, 37, 178-83.
55. Zhang P, Han Y, Huang L, et al. Expression and Clinical Significance of TTF-1 and p63 in NSCLC. Zhongguo Fei Ai Za Zhi 2009, 12, 995-9.
56. Larsen JE, Colosimo ML, Yang IA, et al. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control 2005, 16, 579-85.
57. Larsen JE, Colosimo ML, Yang IA, et al. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis 2006, 27, 525-32.
58. Wright CM, Larsen JE, Colosimo ML, et al. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J 2010, 35, 152-9.
59. Han JY, Lee YS, Shin ES, et al. A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. Pharmacogenomics J 2013. [Epub ahead of print].
60. Liu JZ, Tozzi F, Waterworth DM, et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010, 42, 436-40.
61. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010, 42, 441-7.
62. Thorgeirsson TE, Gudbjartsson DF, Surakka I, et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010, 42, 448-53.
63. Siedlinski M, Cho MH, Bakke P, et al. Genome-wide association study of smoking behaviours in patients with COPD. Thorax 2011, 66, 894-902.
64. Saccone NL, Culverhouse RC, Schwantes-An TH, et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet 2010, 6:e1001053.
65. David SP, Hamidovic A, Chen GK, et al. Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry 2012, 2:e119.
66. Kumasaka N, Aoki M, Okada Y, et al. Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a Japanese population. PLoS One 2012, 7:e44507.
67. Fung PR, Snape-Jenkinson SL, Godfrey MT, et al. Effectiveness of hospitalbased smoking cessation. Chest 2005, 128, 216-23.
68. Yang IA, Relan V, Wright CM, et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 2011, 15, 439-56.
69. Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer 2013, 13, 233-45.
70. El-Zein RA, Young RP, Hopkins RJ, et al. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila) 2012, 5, 522-7.
71. Wilk JB, Chen TH, Gottlieb DJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009, 5:e1000429.
72. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5:e1000421.
73. Cho MH, Boutaoui N, Klanderman BJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010, 42, 200-2.
74. Cho MH, Castaldi PJ, Wan ES, et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 2012, 21, 947-57.
75. Wilk JB, Shrine NR, Loehr LR, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012, 186, 622-32.
76. Bosse Y. Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis 2012, 7, 607-31.
77. Zhou X, Qiu W, Sathirapongsasuti JF, et al. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics 2013, 101, 263-72.
78. Young RP, Hopkins RJ, Hay BA, et al. FAM13A locus in COPD is independently associated with lung cancer - evidence of a molecular genetic link between COPD and lung cancer. Appl Clin Genet 2010, 4, 1-10.
79. Sriram KB, Larsen JE, Savarimuthu Francis SM, et al. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS One 2012, 7:e30398.
80. Davidson MR, Larsen JE, Yang IA, et al. Microrna-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma. PLoS ONE 2010, 5:e12560.
81. Larsen JE, Pavey SJ, Bowman R, et al. Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J 2007, 30, 21-5.
82. Larsen JE, Pavey SJ, Passmore LH, et al. Expression profiling defines a recurrence signature in lung squamous cell carcinoma. Carcinogenesis 2007, 28, 760-6.
83. Larsen JE, Pavey SJ, Passmore LH, et al. Gene expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer Res 2007, 13, 2946-54.
84. Daniels M, Goh F, Wright CM, et al. Whole genome sequencing for lung cancer. J Thorac Dis 2012, 4, 155-63.
85. Silverman EK. Perspective: how can genetics help? Nature 2012, 489:S7.